| Nov 14 |
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
|
| Nov 13 |
Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues
|
| Nov 9 |
Royalty Pharma: Massive Opportunity Ahead
|
| Nov 7 |
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
|
| Nov 7 |
Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions
|
| Nov 7 |
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight
|
| Nov 6 |
Royalty Pharma plc (RPRX) Q3 2024 Earnings Call Transcript
|
| Nov 6 |
Royalty Pharma plc 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 6 |
Royalty Pharma reports Q3 results, raises FY guidance
|
| Nov 6 |
Royalty Pharma Reports Third Quarter 2024 Results
|
